Related references
Note: Only part of the references are listed.Variants in genes coding for collagen type IV α-chains are frequent causes of persistent, isolated hematuria during childhood
Joseph L. Alge et al.
PEDIATRIC NEPHROLOGY (2023)
Molecular and Cellular Mechanisms Underlying the Initiation and Progression of Alport Glomerular Pathology
Dominic Cosgrove et al.
FRONTIERS IN MEDICINE (2022)
Non-Immunosuppressive Cyclophilin Inhibitors
Cordelia Schiene-Fischer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)
Discovery and molecular basis of subtype-selective cyclophilin inhibitors
Alexander A. Peterson et al.
NATURE CHEMICAL BIOLOGY (2022)
Complexities of the glomerular basement membrane
Richard W. Naylor et al.
NATURE REVIEWS NEPHROLOGY (2021)
Cyclophilin D: An Integrator of Mitochondrial Function
Georgios Amanakis et al.
FRONTIERS IN PHYSIOLOGY (2020)
Trimerization and Genotype-Phenotype Correlation of COL4A5 Mutants in Alport Syndrome
Misato Kamura et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome
Kandai Nozu et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2020)
Alport syndrome and Pierson syndrome: Diseases of the glomerular basement membrane
Steven D. Funk et al.
MATRIX BIOLOGY (2018)
Cyclophilin D, Somehow a Master Regulator of Mitochondrial Function
George A. Porter et al.
BIOMOLECULES (2018)
A Split-Luciferase-Based Trimer Formation Assay as a High-throughput Screening Platform for Therapeutics in Alport Syndrome
Kohei Omachi et al.
CELL CHEMICAL BIOLOGY (2018)
Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome
Dominic Cosgrove et al.
MATRIX BIOLOGY (2017)
Cyclophilin-B Modulates Collagen Cross-linking by Differentially Affecting Lysine Hydroxylation in the Helical and Telopeptidyl Domains of Tendon Type I Collagen
Masahiko Terajima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations
Judith Savige et al.
PLOS ONE (2016)
Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naive patients with chronic HCV genotype 1 infection (ESSENTIAL II)
S. Zeuzem et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Structural mechanisms of cyclophilin D-dependent control of the mitochondrial permeability transition pore
Manuel Gutierrez-Aguilar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Cyclosporin A may cause injury to undifferentiated glomeruli persisting in patients with Alport syndrome
Keisuke Sugimoto et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2014)
Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain
Yuya Hashimura et al.
KIDNEY INTERNATIONAL (2014)
Abnormal Type I Collagen Post-translational Modification and Crosslinking in a Cyclophilin B KO Mouse Model of Recessive Osteogenesis Imperfecta
Wayne A. Cabral et al.
PLOS GENETICS (2014)
Physiologic Functions of Cyclophilin D and the Mitochondrial Permeability Transition Pore
John W. Elrod et al.
CIRCULATION JOURNAL (2013)
Profile of alisporivir and its potential in the treatment of hepatitis C
Philippe A. Gallay et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Glomerular basement membrane composition and the filtration barrier
Jeffrey H. Miner
PEDIATRIC NEPHROLOGY (2011)
Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle
Dirk Daelemans et al.
ANTIVIRAL RESEARCH (2010)
The Alport Syndrome COL4A5 Variant Database
David K. Crockett et al.
HUMAN MUTATION (2010)
Structural Basis of Cyclophilin B Binding by the Calnexin/Calreticulin P-domain
Guennadi Kozlov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cyclosporine A treatment in patients with Alport syndrome: a single-center experience
Laura Massella et al.
PEDIATRIC NEPHROLOGY (2010)
Severe Osteogenesis Imperfecta in Cyclophilin B-Deficient Mice
Jae Won Choi et al.
PLOS GENETICS (2009)
Cyclosporin therapy in patients with Alport syndrome
Marina Charbit et al.
PEDIATRIC NEPHROLOGY (2007)
Resolution of proteinuria in a patient with X-linked Alport syndrome treated with cyclosporine
Thorir Svavar Sigmundsson et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2006)
The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro
J Paeshuyse et al.
HEPATOLOGY (2006)
X-linked Alport syndrome:: Natural history and genotype-phenotype correlations in girls and women belonging to 195 families:: A European community Alport syndrome concerted action study
JP Jais et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Cyclosporine A slows the progressive renal disease of Alport syndrome (X-linked hereditary nephritis): Results from a canine model
D Chen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
The chaperone activity of protein disulfide isomerase is affected by cyclophilin B and cyclosporin A in vitro
T Horibe et al.
JOURNAL OF BIOCHEMISTRY (2002)
Functional analysis of the Hsp90-associated human peptidyl prolyl cis/trans isomerases FKBP51, FKBP52 and Cyp40
F Pirkl et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Share Paper
